
Deep inside virtually every human cell sit hundreds of tiny biological generators known as mitochondria. They burn nutrients to produce adenosine triphosphate (ATP), the chemical fuel that powers everything from muscle contractions to quiet thought.
Yet when these power stations come under stress, things can turn messy. Their internal machinery begins to leak electrons, creating reactive oxygen species (ROS)—unstable free radicals that chew through delicate cellular structures. Rather than simply mopping up these rogue sparks after they fly, scientists have turned their attention to fixing the engine itself.
Enter SS-31, also known in academic literature as elamipretide. This synthetic tetrapeptide (made of just four amino acids) was designed to slip straight into the inner sanctum of the mitochondrion. Rather than floating aimlessly in the wider cellular fluid, it heads directly to the biological membrane where cellular power generation happens.
What is the SS-31 Mitochondrial Peptide?
SS-31 is an aromatic-cationic tetrapeptide with the specific sequence D-Arg-Dmt-Lys-Phe-NH2. That technical mouthful describes an elegant structural balance: it possesses positive electrical charges paired with aromatic rings, allowing it to easily cross biological membranes.
Once inside a cell, the natural electrical gradient of active mitochondria pulls the peptide inward. It settles neatly onto the inner mitochondrial membrane.
Crucially, chemists built SS-31 using unnatural D-amino acids. Ordinary peptides built from standard L-amino acids are rapidly broken down by metabolic enzymes, but the D-amino backbone acts like a biological shield, granting SS-31 resilience against enzymatic degradation and extending its stability in experimental systems.
Why is everyone talking about cardiolipin?
To understand how SS-31 works, you need to meet cardiolipin. Cardiolipin is a specialised phospholipid found almost exclusively within the folds of the inner mitochondrial membrane.
Think of cardiolipin as the biological scaffolding that holds the electron transport chain (ETC) in place. When cellular stress occurs, cardiolipin oxidises and warps out of shape. Without sturdy scaffolding, the complexes of the electron transport chain drift out of alignment, electron leaks spike, ROS production surges, and ATP output plummets.
Laboratory models suggest that SS-31 binds reversibly to cardiolipin, shielding it from peroxidation and stabilising its physical architecture. By defending this structural foundation, the peptide helps support several critical mitochondrial processes:
- **Tightening electron flow:** Keeping ETC complexes I, III, and IV properly aligned minimises electron leakage, cutting down reactive oxygen species right at their point of origin.
- **Tamping down oxidative stress:** By tackling electron leakage at the source, SS-31 reduces the initial surge of superoxide radicals.
- **Preserving mitochondrial dynamics:** Research models indicate it helps maintain the natural balance between mitochondrial fission (splitting) and fusion (merging), which keeps cellular networks healthy.
- **Supporting cellular bioenergetics:** By preserving the membrane machinery needed to generate ATP, cells retain the energy reserves required to handle stress.
- **Delaying programmed cell death:** Severe mitochondrial collapse triggers apoptosis (cell suicide), including the release of cytochrome c. Preserving membrane stability helps stave off premature cellular demise.
What does the research actually explore?
Preclinical laboratories have investigated SS-31 across a wide range of organ models where mitochondrial distress plays a leading role.
Cardiovascular Research The heart consumes vast amounts of oxygen and energy, making it acutely sensitive to oxygen deprivation. In rodent models of myocardial ischemia-reperfusion (I/R) injury—where tissue is starved of blood flow and then abruptly flooded again—a 2011 *Circulation Research* paper found that giving SS-31 before reperfusion reduced infarct size, lowered oxidative stress, and protected mitochondrial function.

A subsequent 2013 study in the *American Journal of Physiology - Heart and Circulatory Physiology* reported that the peptide helped maintain mitochondrial cristae structure and curbed the release of cytochrome c, supporting post-injury cardiac function in animals.
Renal and Kidney Studies Like the heart, the kidneys rely heavily on mitochondrial fuel to filter waste and manage electrolyte balances. A 2014 study published in the *Journal of the American Society of Nephrology* noted that SS-31 preserved mitochondrial integrity and reduced tubular damage in rodent models of acute kidney injury. Later work in *Kidney International* (2016) highlighted its ability to suppress mitochondrial breakdown and tubular cell death, suggesting a supportive role for intrinsic tissue repair.
Neurological Models The brain accounts for a massive slice of resting metabolic energy. In a 2012 *Journal of Neuroscience* paper, SS-31 reduced neuronal damage and improved outcomes in rodent models of cerebral ischemia by guarding against excitotoxicity and mitochondrial collapse. Moving into neurodegenerative models, a 2016 study in *JAMA Neurology* examined its potential in models of Alzheimer's disease, reporting improvements in mitochondrial bioenergetics and reduced synaptic dysfunction.
Metabolic and Ocular Investigations Researchers have also probed metabolic stress. A 2015 *Diabetes* study tested SS-31 in rodent models of diet-induced obesity and type 2 diabetes, showing improved mitochondrial function alongside reduced insulin resistance in both skeletal muscle and liver tissue. In 2017, a *Cell Metabolism* paper showed protection against glucose toxicity in pancreatic beta-cells.
Meanwhile, a 2015 study in *Investigative Ophthalmology & Visual Science* found that SS-31 protected retinal ganglion cells from oxidative damage in preclinical glaucoma models.
How SS-31 compares to other mitochondrial compounds
Scientists have studied several strategies to help struggling mitochondria, ranging from general antioxidants to targeted uncouplers. The difference often comes down to *where* and *how* the compound acts.
| Feature | SS-31 (Elamipretide) | MitoQ | General Antioxidants (e.g. Vitamin C) | Mitochondrial Uncouplers (e.g. DNP) |
|---|---|---|---|---|
| **Mitochondrial Specificity** | High (inner membrane) | High (inner membrane) | Low (general, cytoplasmic) | Moderate (disrupts gradient) |
| **Primary Mechanism** | Cardiolipin stabilization, ETC support | ROS scavenger (ubiquinone analog) | ROS scavenger | Disrupts ATP synthesis to create heat |
| **Action Point** | Reduces initial ROS generation | Scavenges existing ROS | Scavenges existing ROS | Alters energy metabolism |
| **Impact on ATP** | Preserves or supports synthesis | Indirect support via lower damage | Indirect support via lower damage | Reduces ATP production |
| **Observed Toxicity** | Generally low in research models | Moderate in some models | Generally low | High |
While a molecule like MitoQ concentrates in the mitochondria to mop up free radicals that have already formed, SS-31 acts further upstream. By physically stabilising cardiolipin, it helps prevent the electron transport chain from misfiring in the first place.
Important things to understand
While preclinical data across cell cultures and animal models is extensive, several major research questions remain unanswered.
First, long-term safety and efficacy profiles are still under scrutiny. The bulk of published research explores acute damage models; how tissues adapt to chronic, long-term exposure to cardiolipin-modulating peptides over months or years remains unclear.
Second, the molecular details of its interaction with cardiolipin require higher-resolution structural mapping. Researchers are still untangling whether SS-31 influences other mitochondrial signalling pathways or behaves differently across diverse cell types. Furthermore, questions remain around how the peptide might interact with standard-of-care therapies or other regenerative approaches, such as gene or stem cell therapies.
In laboratory settings, handling SS-31 requires meticulous protocol control. Researchers store the lyophilised powder at -20°C or -80°C to guard against degradation, reconstituting it in sterile aqueous buffers like water or phosphate-buffered saline (PBS) and avoiding repeated freeze-thaw cycles. Because cell culture environments (such as ambient glucose and oxygen concentrations) dramatically alter baseline mitochondrial respiration, preclinical trials must rely on precise metabolic assays—such as oxygen consumption rate (OCR) and extracellular acidification rate (ECAR)—to measure true bioenergetic effects.
SS-31 is an experimental research compound under ongoing scientific investigation. It is not an approved medicine, dietary supplement, or therapy, and it is strictly intended for scientific laboratory research rather than human consumption.
Further reading on Peptide Intel Hub: verified research suppliers, how to read a certificate of analysis, every protocol from A to Z.
Quick questions, clear answers
What is SS-31?+
SS-31 (also called elamipretide) is a synthetic tetrapeptide engineered to cross cellular membranes and concentrate on the inner mitochondrial membrane, where it binds to and stabilises cardiolipin.
How does SS-31 differ from conventional antioxidants?+
Unlike broad-spectrum antioxidants that clear up free radicals after they form, SS-31 binds to cardiolipin in the inner mitochondrial membrane. This helps maintain the structure of the electron transport chain, reducing electron leakage and oxidative stress at the point of origin.
What conditions have researchers studied with SS-31?+
SS-31 has been investigated in laboratory and animal models of cardiovascular ischemia-reperfusion, acute kidney injury, cerebral ischemia, Alzheimer's models, and metabolic conditions like diet-induced insulin resistance.
Is SS-31 approved for clinical use?+
No. SS-31 is an investigational compound intended strictly for laboratory and preclinical research. It is not approved for general medical use or human consumption.
Keep reading
More in Energy & Mitochondrial Research

SS-31 Peptide Stability: Laboratory Science Guide
Explore the science behind SS-31 stability. Discover how temperature, light, and freeze-thaw cycles impact this mitochondrial peptide during laboratory research.

MOTS-c: Inside the Mitochondrial-Derived Peptide
Encoded inside mitochondria, MOTS-c is a unique 16-amino-acid peptide studied for its exercise-mimicking signals, AMPK activation, and links to healthy ageing.

MOTS-c and SS-31: Inside Mitochondrial Research
Explore how MOTS-c and SS-31 approach mitochondrial ageing from different angles: one as a genetic messenger, the other as a structural repair agent.
Related guides & studies
SS-31 research worldwide
How peptide research is regulated and discussed in each region we cover.
References & clinical studies
No identified primary paper is recorded for this overview. Use the discovery links below to locate original studies; a search is not a citation or confirmation of the claims on this page.
